Society of Gynecologic Oncologists Clinical Practice Committee Statement on Prophylactic Salpingo-oophorectomy

Gynecologic Oncology

Volumn 98, Issue 2, 2005, Pages 179-181

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; COST OF ILLNESS; DELETION MUTANT; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GYNECOLOGY; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MORBIDITY; ONCOLOGY; OVARY CANCER; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RISK ASSESSMENT; RISK REDUCTION; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA;

EID: 22544488380     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.05.002     Document Type: Editorial

References (16)

1. J.P. Struewing, P. Hartge, and S. Wacholder The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N. Engl. J. Med. 336 1997 1401 1408
2. D. Ford, D.F. Easton, and M. Stratton Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am. J. Hum. Genet. 62 1998 676 689
3. N.D. Kauff, J.M. Satagopan, and M.E. Robson Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N. Engl. J. Med. 346 2002 1609 1615
4. T.R. Rebbeck, H.T. Lynch, and S.L. Neuhausen Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N. Engl. J. Med. 346 2002 1616 1622
5. J.L. Rutter, S. Wacholder, and A. Chetrit Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study J. Natl. Cancer Inst. 95 2003 1072 1078
6. J.M. Satagopan, J. Boyd, and N.D. Kauff Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Clin. Cancer Res. 8 2002 3776 3781
7. M.C. King, J.H. Marks, and J.B. Mandell New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
8. T.R. Rebbeck, A.M. Levin, and A. Eisen Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J. Natl. Cancer Inst. 91 1999 1475 1479
9. K.H. Lu, J.E. Garber, and D.W. Cramer Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J. Clin. Oncol. 18 2000 2728 2732
10. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am. J. Surg. Pathol. 25 2001 1283 1289
11. C.B. Powell, E. Kenley, and L.M. Chen Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J. Clin. Oncol. 23 2005 127 132
12. T.J. Colgan, S.L. Boerner, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy Gynecol. Oncol. 85 2002 397 403
13. S. Aziz, G. Kuperstein, and B. Rosen A genetic epidemiological study of carcinoma of the fallopian tube Gynecol. Oncol. 80 2001 341 345
14. B.Y. Karlan Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis Gynecol. Oncol. 92 2004 519 520
15. O. Lavie, G. Hornreich, and A. Ben-Arie BRCA germline mutations in Jewish women with uterine serous papillary carcinoma Gynecol. Oncol. 92 2004 521 524
16. S. Skates, R. Troiano, and R.C. Knapp Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum Int. J. Gynecol. Cancer 13 2003 693 696